USD499802S1 - Powder inhaler - Google Patents

Powder inhaler Download PDF

Info

Publication number
USD499802S1
USD499802S1 US29/178,877 US17887703F USD499802S US D499802 S1 USD499802 S1 US D499802S1 US 17887703 F US17887703 F US 17887703F US D499802 S USD499802 S US D499802S
Authority
US
United States
Prior art keywords
powder inhaler
view
inhaler shown
elevated
cover
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US29/178,877
Inventor
John Pinon
Sameer Shirgaonkar
Christopher James Smith
Simon Burge
Max William Middleton
David Ahern
Matthew Neil Sarkar
Ben Arlett
Emma Lesley Lye
Simon Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chiesi Farmaceutici SpA
Original Assignee
Chiesi Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici SpA filed Critical Chiesi Farmaceutici SpA
Priority to US29/178,877 priority Critical patent/USD499802S1/en
Assigned to CHIESI FARMACEUTICI S.P.A. reassignment CHIESI FARMACEUTICI S.P.A. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AHERN, DAVID, ARLETT, BEN, BURGE, SIMON, LYE, EMMA LESLEY, MIDDLETON, MAX WILLIAM, SARKAR, MATTHEW NEIL, SMITH, SIMON, SMITH, CHRISTOPHER JAMES, SHIRGAONKAR, SAMEER, PINON, JOHN
Application granted granted Critical
Publication of USD499802S1 publication Critical patent/USD499802S1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Description

FIG. 1 is a side perspective view of a powder inhaler showing our new design, with the cover shown in closed position;
FIG. 2 is a s side perspective view of the powder inhaler shown in FIG. 1 with the cover being disposed in an open position;
FIG. 3 is an elevated right side view of the powder inhaler shown in FIG. 1;
FIG. 4 is an elevated back side view of the powder inhaler shown in FIG. 1;
FIG. 5 is an elevated left side view of the powder inhaler shown in FIG. 2;
FIG. 6 is a top perspective view of the powder inhaler shown in FIG. 2;
FIG. 7 is a top perspective view of a second embodiment of the powder inhaler shown in FIG. 1, the only difference being that the cover has a violet color, it being understood that all other surfaces are the same as those of the first embodiment;
FIG. 8 is a side perspective view of the powder inhaler shown in FIG. 7 with the cover being disposed in an open position;
FIG. 9 is an elevated right side view of the powder inhaler shown in FIG. 7;
FIG. 10 is an elevated back side view of the powder inhaler shown in FIG. 7;
FIG. 11 is an elevated left side view of the powder inhaler shown in FIG. 8;
FIG. 12 is a top perspective view of the powder inhaler shown in FIG. 8;
FIG. 13 is a top perspective view of a third embodiment of the powder inhaler shown in FIG. 1, the only difference being that the cover has an orange color, it being understood that all other surfaces are the same as those of the first embodiment;
FIG. 14 is a side perspective view of the powder inhaler shown in FIG. 13 with the cover being disposed in an open position;
FIG. 15 is an elevated right side view of the powder inhaler shown in FIG. 13;
FIG. 16 is an elevated back side view of the powder inhaler shown in FIG. 13;
FIG. 17 is an elevated left side view of the powder inhaler shown in FIG. 14;
FIG. 18 is a top perspective view of the powder inhaler shown in FIG. 14;
FIG. 19 is a top perspective view of a fourth embodiment of the powder inhaler shown in FIG. 1, the only difference being that the cover has a green color, it being understood that all other surfaces are the same as those of the first embodiment;
FIG. 20 is a side perspective view of the powder inhaler shown in FIG. 19 with the cover being disposed in an open position;
FIG. 21 is an elevated right side view of the powder inhaler shown in FIG. 19;
FIG. 22 is an elevated back side view of the powder inhaler shown in FIG. 19;
FIG. 23 is an elevated left side view of the powder inhaler shown in FIG. 20;
FIG. 24 is a top perspective view of the powder inhaler shown in FIG. 20;
FIG. 25 is a top perspective view of a fifth embodiment of the powder inhaler shown in FIG. 1, the only difference being that the cover has a burgundy color, it being understood that all other surfaces are the same as those of the first embodiment;
FIG. 26 is a side perspective view of the powder inhaler shown in FIG. 25 with the cover being disposed in an open position;
FIG. 27 is an elevated right side view of the powder inhaler shown in FIG. 25;
FIG. 28 is an elevated back side view of the powder inhaler shown in FIG. 25;
FIG. 29 is an elevated left side view of the powder inhaler shown in FIG. 26;
FIG. 30 is a top perspective view of the powder inhaler shown in FIG. 26;
FIG. 31 is a top perspective view of a sixth embodiment of the powder inhaler shown in FIG. 1, the only difference being that the cover has a blue color, it being understood that all other surfaces are the same as those of the first embodiment;
FIG. 32 is a side perspective view of the powder inhaler shown in FIG. 31 with the cover being disposed in an open position;
FIG. 33 is an elevated right side view of the powder inhaler shown in FIG. 31;
FIG. 34 is an elevated back side view of the powder inhaler shown in FIG. 31;
FIG. 35 is an elevated left side view of the powder inhaler shown in FIG. 32; and,
FIG. 36 is a top perspective view of the powder inhaler shown in FIG. 32.

Claims (1)

  1. The ornamental design for a powder inhaler, as shown and described.
US29/178,877 2003-04-01 2003-04-01 Powder inhaler Expired - Lifetime USD499802S1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US29/178,877 USD499802S1 (en) 2003-04-01 2003-04-01 Powder inhaler

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29/178,877 USD499802S1 (en) 2003-04-01 2003-04-01 Powder inhaler

Publications (1)

Publication Number Publication Date
USD499802S1 true USD499802S1 (en) 2004-12-14

Family

ID=33488896

Family Applications (1)

Application Number Title Priority Date Filing Date
US29/178,877 Expired - Lifetime USD499802S1 (en) 2003-04-01 2003-04-01 Powder inhaler

Country Status (1)

Country Link
US (1) USD499802S1 (en)

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD669791S1 (en) 2011-05-19 2012-10-30 R.J. Reynolds Tobacco Company Spray dispensing container
USD669792S1 (en) 2011-03-10 2012-10-30 R.J. Reynolds Tobacco Company Spray dispensing container
US8424518B2 (en) 2008-06-13 2013-04-23 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
USD745660S1 (en) * 2010-03-26 2015-12-15 Oriel Therapeutics, Inc. Dry powder inhaler
US9220687B2 (en) 2008-12-29 2015-12-29 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9233159B2 (en) 2011-10-24 2016-01-12 Mannkind Corporation Methods and compositions for treating pain
US9241903B2 (en) 2006-02-22 2016-01-26 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US9283193B2 (en) 2005-09-14 2016-03-15 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9358352B2 (en) 2008-06-13 2016-06-07 Mannkind Corporation Dry powder drug delivery system and methods
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US9364436B2 (en) 2011-06-17 2016-06-14 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US9630930B2 (en) 2009-06-12 2017-04-25 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
US9675674B2 (en) 2004-08-23 2017-06-13 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9700690B2 (en) 2002-03-20 2017-07-11 Mannkind Corporation Inhalation apparatus
US9706944B2 (en) 2009-11-03 2017-07-18 Mannkind Corporation Apparatus and method for simulating inhalation efforts
US9796688B2 (en) 2004-08-20 2017-10-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US9802012B2 (en) 2012-07-12 2017-10-31 Mannkind Corporation Dry powder drug delivery system and methods
US9801925B2 (en) 1999-06-29 2017-10-31 Mannkind Corporation Potentiation of glucose elimination
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
US9943571B2 (en) 2008-08-11 2018-04-17 Mannkind Corporation Use of ultrarapid acting insulin
US9983108B2 (en) 2009-03-11 2018-05-29 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
USD855792S1 (en) * 2013-01-30 2019-08-06 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Inhaler device
US10421729B2 (en) 2013-03-15 2019-09-24 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US10625034B2 (en) 2011-04-01 2020-04-21 Mannkind Corporation Blister package for pharmaceutical cartridges
US11446127B2 (en) 2013-08-05 2022-09-20 Mannkind Corporation Insufflation apparatus and methods
USD983354S1 (en) * 2020-12-21 2023-04-11 Rpc Formatec Gmbh Inhaler
USD985760S1 (en) * 2021-10-05 2023-05-09 Neutec Inhaler Ilac Sanayi Ve Ticaret A. S. Inhalation device
USD986406S1 (en) * 2020-07-21 2023-05-16 Nippharma Co., Ltd. Inhaler for powdered medicaments

Cited By (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9801925B2 (en) 1999-06-29 2017-10-31 Mannkind Corporation Potentiation of glucose elimination
US9700690B2 (en) 2002-03-20 2017-07-11 Mannkind Corporation Inhalation apparatus
US9796688B2 (en) 2004-08-20 2017-10-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US10130685B2 (en) 2004-08-23 2018-11-20 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9675674B2 (en) 2004-08-23 2017-06-13 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US10143655B2 (en) 2005-09-14 2018-12-04 Mannkind Corporation Method of drug formulation
US9717689B2 (en) 2005-09-14 2017-08-01 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9446001B2 (en) 2005-09-14 2016-09-20 Mannkind Corporation Increasing drug affinity for crystalline microparticle surfaces
US9283193B2 (en) 2005-09-14 2016-03-15 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9241903B2 (en) 2006-02-22 2016-01-26 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US10130581B2 (en) 2006-02-22 2018-11-20 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US9339615B2 (en) 2008-06-13 2016-05-17 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9511198B2 (en) 2008-06-13 2016-12-06 Mannkind Corporation Dry powder inhaler and system for drug delivery
US10342938B2 (en) 2008-06-13 2019-07-09 Mannkind Corporation Dry powder drug delivery system
US9358352B2 (en) 2008-06-13 2016-06-07 Mannkind Corporation Dry powder drug delivery system and methods
US8636001B2 (en) 2008-06-13 2014-01-28 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8424518B2 (en) 2008-06-13 2013-04-23 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9393372B2 (en) 2008-06-13 2016-07-19 Mannkind Corporation Dry powder drug delivery system
US9446133B2 (en) 2008-06-13 2016-09-20 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
US8912193B2 (en) 2008-06-13 2014-12-16 Mannkind Corporation Dry powder inhaler and system for drug delivery
US10751488B2 (en) 2008-06-13 2020-08-25 Mannkind Corporation Dry powder inhaler and system for drug delivery
US10201672B2 (en) 2008-06-13 2019-02-12 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8499757B2 (en) 2008-06-13 2013-08-06 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9662461B2 (en) 2008-06-13 2017-05-30 Mannkind Corporation Dry powder drug delivery system and methods
US9192675B2 (en) 2008-06-13 2015-11-24 Mankind Corporation Dry powder inhaler and system for drug delivery
US10675421B2 (en) 2008-06-20 2020-06-09 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US9943571B2 (en) 2008-08-11 2018-04-17 Mannkind Corporation Use of ultrarapid acting insulin
US9655850B2 (en) 2008-12-29 2017-05-23 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9220687B2 (en) 2008-12-29 2015-12-29 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US10172850B2 (en) 2008-12-29 2019-01-08 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9983108B2 (en) 2009-03-11 2018-05-29 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US9630930B2 (en) 2009-06-12 2017-04-25 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
US9706944B2 (en) 2009-11-03 2017-07-18 Mannkind Corporation Apparatus and method for simulating inhalation efforts
USD745660S1 (en) * 2010-03-26 2015-12-15 Oriel Therapeutics, Inc. Dry powder inhaler
USD669792S1 (en) 2011-03-10 2012-10-30 R.J. Reynolds Tobacco Company Spray dispensing container
US10625034B2 (en) 2011-04-01 2020-04-21 Mannkind Corporation Blister package for pharmaceutical cartridges
USD669791S1 (en) 2011-05-19 2012-10-30 R.J. Reynolds Tobacco Company Spray dispensing container
US9364436B2 (en) 2011-06-17 2016-06-14 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US10130709B2 (en) 2011-06-17 2018-11-20 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US10258664B2 (en) 2011-10-24 2019-04-16 Mannkind Corporation Methods and compositions for treating pain
US9233159B2 (en) 2011-10-24 2016-01-12 Mannkind Corporation Methods and compositions for treating pain
US9610351B2 (en) 2011-10-24 2017-04-04 Mannkind Corporation Methods and compositions for treating pain
US9802012B2 (en) 2012-07-12 2017-10-31 Mannkind Corporation Dry powder drug delivery system and methods
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
USD855792S1 (en) * 2013-01-30 2019-08-06 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Inhaler device
US10421729B2 (en) 2013-03-15 2019-09-24 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
US11446127B2 (en) 2013-08-05 2022-09-20 Mannkind Corporation Insufflation apparatus and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
USD986406S1 (en) * 2020-07-21 2023-05-16 Nippharma Co., Ltd. Inhaler for powdered medicaments
USD983354S1 (en) * 2020-12-21 2023-04-11 Rpc Formatec Gmbh Inhaler
USD985760S1 (en) * 2021-10-05 2023-05-09 Neutec Inhaler Ilac Sanayi Ve Ticaret A. S. Inhalation device

Similar Documents

Publication Publication Date Title
USD499802S1 (en) Powder inhaler
USD529344S1 (en) Softside cooler
USD518171S1 (en) Inhaler
USD509898S1 (en) Inhaler
USD522376S1 (en) Leaf shaped box
USD627194S1 (en) Cooking container with ornamentation
USD478689S1 (en) Cosmetic case
USD499927S1 (en) Coffee machine
USD440203S1 (en) Multiple outlet adapter
USD522319S1 (en) Nestable container
USD526064S1 (en) Clamshell dental cassette
USD488718S1 (en) Tray with cover
USD461047S1 (en) Key fob
USD427171S (en) Handset
USD435547S (en) Telephone mouthpiece cover
USD505856S1 (en) Electrical outlet cover plate
USD524948S1 (en) Electrophoresis device
AU2001293704A1 (en) Tridentate ligands and their complexes with transition metals
USD503282S1 (en) Cover for a paintbrush
AU2002220588A1 (en) Tridentate ligands and relative complexes with transition metals
USD504635S1 (en) Ring
USD558267S1 (en) Book with cover flap
USD550747S1 (en) Combined projector and receiving device
USD476116S1 (en) Pocket planner
USD477768S1 (en) Security lockout hasp

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY